1
2
3
4
5
6
Por Staflin, Karin, Krueger, Joseph S, Hachmann, Janna, Forsyth, Jane S, Lorger, Mihaela, Steiniger, Sebastian CJ, Mee, Jenny, Pop, Cristina, Salvesen, Guy S, Janda, Kim D, Felding-Habermann, Brunhilde
Publicado no Clin Exp Metastasis (2010)
Obter o texto integralPublicado no Clin Exp Metastasis (2010)
Obter o texto integral
Obter o texto integral
Artigo
7
Por Vessillier, Sandrine, Fort, Madeline, O'Donnell, Lynn, Hinton, Heather, Nadwodny, Kimberly, Piccotti, Joseph, Rigsby, Peter, Staflin, Karin, Stebbings, Richard, Mekala, Divya, Willingham, Aarron, Wolf, Babette
Publicado no Cytokine X (2020)
Obter o texto integralPublicado no Cytokine X (2020)
Obter o texto integral
Obter o texto integral
Artigo
8
Por Weber, Martin R., Zuka, Masahiko, Lorger, Mihaela, Tschan, Mario, Torbett, Bruce E., Zijlstra, Andries, Quigley, James P., Staflin, Karin, Eliceiri, Brian P., Krueger, Joseph S., Marchese, Patricia, Ruggeri, Zaverio M., Felding, Brunhilde H.
Publicado no Thromb Res (2016)
Obter o texto integralPublicado no Thromb Res (2016)
Obter o texto integral
Obter o texto integral
Artigo
9
Target arm affinities determine preclinical efficacy and safety of anti-HER2/CD3 bispecific antibody
Por Staflin, Karin, Zuch de Zafra, Christina L., Schutt, Leah K., Clark, Vanessa, Zhong, Fiona, Hristopoulos, Maria, Clark, Robyn, Li, Ji, Mathieu, Mary, Chen, Xiaocheng, Johnston, Jennifer, Low, Justin, Ybarra, Ryan, Slaga, Dionysos, Yang, Jihong, Ovacik, Meric, Dybdal, Noël O., Totpal, Klara, Junttila, Melissa R., Ellerman, Diego, Lee, Genee, Dennis, Mark S., Prell, Rodney, Junttila, Teemu T.
Publicado no JCI Insight (2020)
Obter o texto integralPublicado no JCI Insight (2020)
Obter o texto integral
Obter o texto integral
Artigo